National Bank of Canada’s CollPlant Biotechnologies CLGN Stock Holding History

National Bank of Canada’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-250	Closed	-$670	–	2917
2025 Q3	$670	Hold	250	–	–	﹤0.01%	2673
2025 Q2	$338	Hold	250	–	–	﹤0.01%	2793
2025 Q1	$642	Hold	250	–	–	﹤0.01%	2620
2024 Q4	$900	Hold	250	–	–	﹤0.01%	2657
2024 Q3	$1.24K	Hold	250	–	–	﹤0.01%	2407
2024 Q2	$1.24K	Hold	250	–	–	﹤0.01%	2482
2024 Q1	$1.62K	Hold	250	–	–	﹤0.01%	2482
2023 Q4	$1.5K	Hold	250	–	–	﹤0.01%	2496
2023 Q3	$1.42K	Hold	250	–	–	﹤0.01%	2551
2023 Q2	$1.98K	Hold	250	–	–	﹤0.01%	2471
2023 Q1	$1.7K	Hold	250	–	–	﹤0.01%	2466
2022 Q4	$2.09K	Hold	250	–	–	﹤0.01%	2481
2022 Q3	$2K	Buy	+250	New	+$2.03K	﹤0.01%	2492

Other funds holding CLGN

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

National Bank of Canada's CLGN Position: Q4 2025 in Review

National Bank of Canada sold out of CollPlant Biotechnologies (CLGN) in Q4 2025, closing a stake of 250 shares — an estimated $670 sold.

National Bank of Canada first reported a position in CLGN in Q3 2022 and held it in 13 quarters. The position peaked at $2.09K in Q4 2022. 17 funds tracked by Wall St. Rank hold CLGN as of Q4 2025.

National Bank of Canada reported no remaining CollPlant Biotechnologies position as of Q4 2025 after selling out during the quarter.
National Bank of Canada sold 250 CollPlant Biotechnologies shares in Q4 2025, an estimated $670.
National Bank of Canada first reported a position in CollPlant Biotechnologies in Q3 2022 and held it in 13 quarters.
National Bank of Canada's CollPlant Biotechnologies position peaked at $2.09K in Q4 2022.
17 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.